Eli Lilly and Company (NYSE:LLY) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2023 Earnings Call. [Operator Instructions].
Source: insidermonkey.com
Page 45 - David Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Ricks Today - Breaking & Trending Today
Drugmakers Promised Cheaper Insulin but Diabetics Can't Find It
Lawmakers are debating whether to simply cap how much people pay for insulin or to tackle the root issues that have driven up the cost of medicine. Addressing the problem is critical. More than 7 million American need insulin daily and paying for it is eating up a greater share of their household income than ever before.
Source: bloomberglaw.com
Eli Lilly stock up in premarket as Mounjaro diabetes drug sales surge
Eli Lilly and Co (NYSE:LLY) stock is seen higher ahead of Tuesday’s open after the company reported a strong, expectations-beating, second-quarter...
Source: proactiveinvestors.com
Promise of Eli Lilly's expected obesity drug, great Q2 adds $60 billion in market cap
In addition to strong earnings, Eli Lilly's prospects were brightened by encouraging trial results from its obesity-drug competitor Novo Nordisk.
Source: cnbc.com
Lilly reports surging profit, raises full-year guidance – Indianapolis Business Journal
The Indianapolis-based pharmaceutical company's first-quarter performance was driven by strong sales of leading drugs for diabetes, cancer and other diseases.
Source: ibj.com